Healthcare provider profile · identity verified

Shelley A Stanforth, MD

Family Practice · MAINEVILLE, OH · NPI 1689774085

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	480	141
Amlodipine Besylate	Amlodipine Besylate	311	91
Lisinopril	Lisinopril	258	69
Levothyroxine Sodium	Levothyroxine Sodium	239	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	220	28
Gabapentin	Gabapentin	176	59
Metoprolol Succinate	Metoprolol Succinate	176	55
Losartan Potassium	Losartan Potassium	144	38
Farxiga	Dapagliflozin Propanediol	128	26
Omeprazole	Omeprazole	126	42
Rosuvastatin Calcium	Rosuvastatin Calcium	121	39
Pantoprazole Sodium	Pantoprazole Sodium	112	35
Atenolol	Atenolol	104	27
Clonazepam	Clonazepam	99	13
Glimepiride	Glimepiride	99	30
Mounjaro	Tirzepatide	90	15
Trazodone Hcl	Trazodone Hcl	87	22
Metformin Hcl Er	Metformin Hcl	78	21
Hydrochlorothiazide	Hydrochlorothiazide	77	24
Pravastatin Sodium	Pravastatin Sodium	77	22
Tramadol Hcl	Tramadol Hcl	75	14
Sertraline Hcl	Sertraline Hcl	74	25
Ozempic	Semaglutide	72	17
Trulicity	Dulaglutide	71	14
Albuterol Sulfate Hfa	Albuterol Sulfate	69	34
Alprazolam	Alprazolam	69	suppressed
Famotidine	Famotidine	65	25
Furosemide	Furosemide	64	27
Jardiance	Empagliflozin	61	21
Metformin Hcl	Metformin Hcl	59	22
Pregabalin	Pregabalin	58	11
Tizanidine Hcl	Tizanidine Hcl	58	18
Duloxetine Hcl	Duloxetine Hcl	55	17
Metoprolol Tartrate	Metoprolol Tartrate	54	17
Montelukast Sodium	Montelukast Sodium	53	20
Clopidogrel	Clopidogrel Bisulfate	52	17
Allopurinol	Allopurinol	50	14
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Simvastatin	Simvastatin	49	14
Spironolactone	Spironolactone	47	14
Donepezil Hcl	Donepezil Hcl	46	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	12
Cephalexin	Cephalexin	43	39
Eliquis	Apixaban	43	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	15
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	40	suppressed
Meloxicam	Meloxicam	40	18
Prednisone	Prednisone	40	31
Carvedilol	Carvedilol	39	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Bupropion Xl	Bupropion Hcl	38	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	12
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Alendronate Sodium	Alendronate Sodium	34	15
Finasteride	Finasteride	34	suppressed
Irbesartan	Irbesartan	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	11
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	11
Lorazepam	Lorazepam	29	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Valsartan	Valsartan	28	11
Calcitriol	Calcitriol	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Lovastatin	Lovastatin	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Azithromycin	Azithromycin	23	15
Potassium Chloride	Potassium Chloride	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Diazepam	Diazepam	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Fluconazole	Fluconazole	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Linzess	Linaclotide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Gemtesa	Vibegron	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Estradiol	Estradiol	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Verapamil Er Pm	Verapamil Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error